Log in to save to my catalogue

VAV3 mediates resistance to breast cancer endocrine therapy

VAV3 mediates resistance to breast cancer endocrine therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_521200

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Endocrine therapies targeting cell proliferation and survival mediated by estrogen receptor α (ERα) are among the most effective systemic treatments for ERα-positive breast cancer. However, most tumors initially responsive to these therapies acquire resistance through mechanisms that involve ERα transcriptional regulatory plasticity. Herein we iden...

Alternative Titles

Full title

VAV3 mediates resistance to breast cancer endocrine therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_swepub_ki_se_521200

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_521200

Other Identifiers

ISSN

1465-542X,1465-5411

E-ISSN

1465-542X

DOI

10.1186/bcr3664